Shahram Attarian

Citado por

	Total	Desde 2019
Citas	12540	8647
Índice h	50	40
Índice i10	175	136

2000

1000

500

1500

2005200620072008200920102011201220132014201520162017201820192020202120222023202445 80 94 142 152 137 199 215 265 325 423 392 437 662 1010 1355 1642 1758 1940 884

Acceso público

Ver todo

42 artículos

7 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Jean-philippe AzulayDirección de correo verificada de ap-hm.fr
Tanya StojkovicG-H Pitié-SalpêtrièreDirección de correo verificada de psl.aphp.fr
Marc BartoliAix Marseille UniversitéDirección de correo verificada de univ-amu.fr
Dominique Figarella-BrangerDirección de correo verificada de univ-amu.fr
Farzad FatehiProfessor of Neurology, Shariati Hospital, Tehran university of medical sciencesDirección de correo verificada de tums.ac.ir
Luis QuerolAutoimmune Neurology, Neuromuscular Diseases Unit, Hospital de la Santa Creu i Sant Pau, BarcelonaDirección de correo verificada de santpau.cat
Jean-Philippe RANJEVAProfessor of Neurosciences, Aix-Marseille UniversitéDirección de correo verificada de univ-amu.fr
Guillaume BassezSorbonne University - Pitie Salpetriere hospitalDirección de correo verificada de aphp.fr
Kuntzer tDirección de correo verificada de chuv.ch
Arnaud Le TroterIR2 CNRSDirección de correo verificada de univ-amu.fr
Aymeric Ravel-ChapuisUniversity of OttawaDirección de correo verificada de uottawa.ca
Tahseen MozaffarProfessor of Neurology, University of California, irvineDirección de correo verificada de uci.edu
joelle micallefprofesseur pharmacologieDirección de correo verificada de ap-hm.fr
olivier blinprof marseilleDirección de correo verificada de ap-hm.fr
Mickaël GuedjHead of Biometrics, Data & Decision Sciences | NanobiotixDirección de correo verificada de servier.com
Françoise HelmbacherGroup Leader, Aix-Marseille Université (AMU), IBDM, CNRS UMR7288Dirección de correo verificada de univ-amu.fr
Roch GiorgiProfesseur de Santé Publique, Aix-Marseille UniversitéDirección de correo verificada de univ-amu.fr
Olivier ChinotProfesseur d'Oncologie, Aix-Marseille UniversitéDirección de correo verificada de ap-hm.fr
laporte jocelynIGBMC (Inserm, Cnrs, Strasbourg University)Dirección de correo verificada de igbmc.fr
Johann BöhmInserm Research DirectorDirección de correo verificada de igbmc.fr

Seguir

Shahram Attarian

CHU La Timone , Aix-Marseille Université

Dirección de correo verificada de ap-hm.fr - Página principal

Les maladies neuromusculaire et la SLA


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis D Adams, A Gonzalez-Duarte, WD O’Riordan, CC Yang, M Ueda, ... New england journal of medicine 379 (1), 11-21, 2018	2380	2018
Guillain–Barré and Miller Fisher syndromes—new diagnostic classification BR Wakerley, A Uncini, N Yuki Nature Reviews Neurology 10 (9), 537-544, 2014	600	2014
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task … PYK Van den Bergh, PA van Doorn, RDM Hadden, B Avau, ... Journal of the Peripheral Nervous System 26 (3), 242-268, 2021	432	2021
Regional variation of Guillain-Barré syndrome AY Doets, C Verboon, B Van Den Berg, T Harbo, DR Cornblath, ... Brain 141 (10), 2866-2877, 2018	297	2018
Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes K Nguyen, G Bassez, M Krahn, R Bernard, P Laforêt, V Labelle, ... Archives of neurology 64 (8), 1176-1182, 2007	294	2007
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial JF Howard, V Bril, T Vu, C Karam, S Peric, T Margania, H Murai, ... The Lancet Neurology 20 (7), 526-536, 2021	274	2021
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial IN van Schaik, V Bril, N van Geloven, HP Hartung, RA Lewis, G Sobue, ... The Lancet Neurology 17 (1), 35-46, 2018	259	2018
Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial P Gajdos, C Tranchant, B Clair, F Bolgert, B Eymard, T Stojkovic, ... Archives of neurology 62 (11), 1689-1693, 2005	230	2005
MUSK, a new target for mutations causing congenital myasthenic syndrome F Chevessier, B Faraut, A Ravel-Chapuis, P Richard, K Gaudon, ... Human Molecular Genetics 13 (24), 3229-3240, 2004	205	2004
Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia Y Miura, JJ Devaux, Y Fukami, C Manso, M Belghazi, AHY Wong, N Yuki, ... Brain 138 (6), 1484-1491, 2015	204	2015
Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy J Böhm, F Chevessier, AM De Paula, C Koch, S Attarian, C Feger, ... The American Journal of Human Genetics 92 (2), 271-278, 2013	200	2013
Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy E Delmont, C Manso, L Querol, A Cortese, A Berardinelli, A Lozza, ... Brain 140 (7), 1851-1858, 2017	199	2017
Disrupting the right prefrontal cortex alters moral judgement S Tassy, O Oullier, Y Duclos, O Coulon, J Mancini, C Deruelle, S Attarian, ... Social cognitive and affective neuroscience 7 (3), 282-288, 2012	160	2012
Effect of ascorbic acid in patients with Charcot–Marie–Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial J Micallef, S Attarian, O Dubourg, PM Gonnaud, JY Hogrel, T Stojkovic, ... The Lancet Neurology 8 (12), 1103-1110, 2009	156	2009
An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth … S Attarian, JM Vallat, L Magy, B Funalot, PM Gonnaud, A Lacour, ... Orphanet journal of rare diseases 9, 1-15, 2014	143	2014
Multifocal motor neuropathy with and without conduction block: a single entity? E Delmont, JP Azulay, R Giorgi, S Attarian, A Verschueren, D Uzenot, ... Neurology 67 (4), 592-596, 2006	140	2006
Development of a French isometric strength normative database for adults using quantitative muscle testing JY Hogrel, CA Payan, G Ollivier, V Tanant, S Attarian, A Couillandre, ... Archives of physical medicine and rehabilitation 88 (10), 1289-1297, 2007	137	2007
A phase II− III trial of olesoxime in subjects with amyotrophic lateral sclerosis T Lenglet, L Lacomblez, JL Abitbol, A Ludolph, JS Mora, W Robberecht, ... European journal of neurology 21 (3), 529-536, 2014	134	2014
Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations I Conceição, T Damy, M Romero, L Galán, S Attarian, M Luigetti, M Sadeh, ... Amyloid 26 (1), 3-9, 2019	127	2019
Analysis of the DYSF mutational spectrum in a large cohort of patients M Krahn, C Béroud, V Labelle, K Nguyen, R Bernard, G Bassez, ... Human mutation 30 (2), E345-E375, 2009	124	2009

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores